Blood-pressure reduction with LCZ696, a novel dual-acting inhibitor of the angiotensin II receptor and neprilysin: a randomised, double-blind, placebo-controlled, active comparator study - Ruilope, L M; Dukat, A; Böhm, M (Lancet, 2010)
et al.